{"nct_id":"NCT05496231","title":"A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2022-08-22","start_date_type":"ACTUAL","primary_completion_date":"2024-02-23","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}